JavaScript is disabled for your browser. Some features of this site may not work without it.
Site-specific modifications of nanobodies targeting ovarian cancer and innovative bioconjugation methods for the efficient detection of cancer at early stage
Site-specific modifications of nanobodies targeting ovarian cancer and innovative bioconjugation methods for the efficient detection of cancer at early stage